CIRBP and peripheral arterial disease: Such an increase in CIRBP, likely accompanied by continuously high miR-329-3p and possible miR-495-3p expression, would inhibit efficient angiogenesis and wound healing in PAD patients, with, for example, non-healing ulcers.